| [1] |
Arru M, Aldrighetti L, Castoldi R, et al.Analysis of Prognostic Factors nfluencing Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer[J]. World Journal of Surgery, 2008, 32(1):93–103.
|
| [2] |
Vibert E, Canedo L, Adam R. Strategies to treat primary unresectable colorectal liver metastases[J]. Semin Oncol, 2005, 32(6 suppl 8):33–39.
|
| [3] |
Kemeny N. Management of liver metastases from colorectal cancer[J]. Oncology (Williston Park), 2006, 20(10):1161-1176, 1179; discussion 1179-1180, 1185-1166.
|
| [4] |
Lau WY, Lai EC. Hepatic resection for colorectal liver metastases[J]. Singapore Med J, 2007, 48(7):635–639.
|
| [5] |
Taniai N, Akimaru K, Yoshida H, et al. Surgical treatment for better prognosis of patients with liver metastases from colorectal cancer[J]. Hepatogastroenterology, 2007, 54(78):1805–1809.
|
| [6] |
Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer[J]. World J Surg, 2008, 32(1):93–103.
|
| [7] |
Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update[J]. J Hepatobiliary Pancreat Surg, 2008, 15(6):570-580.
|
| [8] |
Hellman S, Weichselbaum RR.Oligometastases[J]. J Clin Oncol, 1995, 13(1):8-10.
|
| [9] |
Benson AB, Venook AP, Bekaii-Saab T, et al. Rectal Cancer, Version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(6):719-728; quiz 728.
|
| [10] |
Weichselbaum RR. Hellman S. Oligometastases revisited[J]. Nat Rev Clin Oncol, 2011, 8(6):378-382.
|
| [11] |
Bentrem DJ, DeMatteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver[J]. Ann Rev Med, 2005, 56:139-156.
|
| [12] |
Abdalla EK. Commentary: Radiofrequency ablation for colorectal liver metastases : do not blame the biology when it is the technology[J]. Amer J Surg, 2009, 197(6):737-739.
|
| [13] |
Hur H, Ko YT, Min BS, et al. Comparative study of reseaction and radiofrequency ablation in the treatment of solitary colorectal liver metastases[J]. Amer J Surg, 2009, 197(6):728-736.
|
| [14] |
Reuter NP, Woodall CE, Scoggins CR, et al. Radiofrequency ablation vs. resection for hepatic colorectal metastasis : therapeutically equivaient?[J]. J Gastrointest Surg, 2009, 13(3):486-491.
|
| [15] |
Dexiang Z, Li R, Ye W, et al. Outcome of patients with colorectal liver metastasis: analysis of 1, 613 consecutive cases[J]. Ann Surg Oncol, 2012, 19(9):2860-2868.
|
| [16] |
Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update[J]. J Hepatobiliary Pancreat Surg, 2008, 15(6):570-580.
|
| [17] |
Timmerman RD, Bizekis CS, Pass HI, et al. Local surgical, ablative, and radiation treatment of metastases[J]. Ca Cancer J Clin, 2009, 59(3):145-170.
|
| [18] |
Van der Voort van Zijp J, Hoekstra HJ, Basson MD. Evolving management of colorectal cancer[J]. World J Gastroenterol, 2008, 14(25):3956-3967.
|
| [19] |
Lochan R, White SA, Manas DM. Liver resection for colorectal liver metastasis[J]. Surgical Oncology, 2007, 16(1):33-45.
|
| [20] |
Adam R, Hoti E, Bredt LC. Oncosurgical strategies for metastatic liver cancer[J]. European Journal of Cancer Supplements, Cir Esp, 2011, 89(1):10-19.
|
| [21] |
Folprecht G, Gruenberger T, Bechstein WO, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial[J]. Lancet Oncol, 2010, 11(1):38-47.
|
| [22] |
Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases[J]. Ann Oncol, 2003, 14 Suppl 2:ii13-ii16.
|
| [23] |
Goldberg RM, Sargent DJ, Morton RF, et al. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial[J]. J Clin Oncol, 2006, 24(21):3347-3353.
|
| [24] |
Benoist S, Nordlinger B. Neoadjuvant treatment before resection of liver metastases[J]. Eur J Surg Oncol, 2007, 33(Suppl 2):S35-41.
|
| [25] |
Adam R, Bhangui P, Poston G, et al. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?[J]. Ann Surg, 2010, 252(5):774-787.
|
| [26] |
Matias M, Casa-Nova M, Faria M, et al.Prognostic Factors after Liver Resection for Colorectal Liver Metastasis[J]. 2015, 28(3):357-349.
|
| [27] |
Choi PW, Kim HC, Kim AY, et al.Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels[J]. J Surg Oncol, 2010, 101(1):66-71.
|
| [28] |
Shibata D, Paty PB, Guillem JG, et al.Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma[J]. Dis Colon Rectum, 2002, 45(6):795-801.
|
| [29] |
Min BS, Kim JS, Kim NK, et al.Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis[J]. Ann Surg Oncol, 2009 , 16(12):3271-3278.
|
| [30] |
Bae SU, Han YD, Cho MS, et al.Oncologic outcomes of colon Cancer patients with extraregional lymph node metastasis: comparison of isolated paraaortic lymph node metastasis with resectable liver metastasis[J]. Ann Surg Oncol, 2016, 23(5):1562-1568.
|
| [31] |
Gagnière J, Dupré A, Chabaud S, et al. Retroperitoneal nodal metastases from colorectal cancer: curable metastases with radicalretroperitoneal lymphadenectomy in selected patients[J]. Eur J Surg Oncol, 2015 , 41(6):731-737.
|
| [32] |
Wong JS, Tan GH, Teo MC.Management of para-aortic lymph node metastasis in colorectal patients: A systemic review[J]. Surgical Oncology, 25(2016) , 411-418.
|
| [33] |
Razik R, Zih FS, Haase E, et al.Long-term outcomes following resection of retroperitoneal recurrence of colorectal cancer[J]. Eur J Surg Oncol, 2014 , 40(6):739-476.
|
| [34] |
Takenoue T, Yamada Y, Miyagawa S, et al.Cisplatin-5-fluorouracil therapy with remarkable effect and 5-year survival for paraaortic lymph node metastases of rectal carcinoma in females: a case report[J]. Jpn J Clin Oncol, 1999, 29(11):582-586.
|